The global
tuberculosis testing market continues to grow as governments and
institutions across the globe continue to make efforts to eradicate
this deadly communicable disease. Statistics gathered by the WHO
state that 9 million people acquired tuberculosis (TB) in 2013 and
1.5 met a fatal end, out of which 360,000 were HIV positive. These
figures are declining with each passing year thanks to the
increasingly effective diagnosis and treatment options offered to
patients. It is estimated that such initiatives were able to save the
lives of 37 million tuberculosis patients between 2000 and 2013.
Browse Full Global
Tuberculosis Testing Market Report With Complete TOC @
http://www.transparencymarketresearch.com/tuberculosis-testing-market.html
Tuberculosis can be
broken down into two types, namely active disease, which can
transform to multi-drug resistant TB or MDR-TB, and latent disease.
Tuberculosis also has a rare form called miliary TB, which occurs
when TB infection finds its way to the bloodstream. The priority
steps to counter MDR-TB are supreme quality of treatment for
drug-susceptible TB to avert MDR-TB, expanding the reach of testing
and detection of MDR-TB cases to remote regions, simplifying the
access to good healthcare, infection control, and strengthening the
political commitment, especially in BRIC nations, which constitute
50% of global TB cases.
Dedicated Efforts of
Non-profit Organizations Drive Global Tuberculosis Testing Market
The efforts taken by
governments, social activists, and several healthcare institutions
have translated into positive results. A ripple effect of these
efforts can also be seen in the growth of the global tuberculosis
testing market. The global tuberculosis testing market was worth
US$1,936.1 million in 2013. By 2020 this market is expected to reach
a valuation of US$2,619.4 million, growing at a promising CAGR of
4.3% from 2014 to 2020.
The factors driving
this gigantic growth are the rising number of tuberculosis cases,
increasing acceptance of innovative methods for treating
tuberculosis, and enhanced molecular and rapid culture diagnostic
tests. The serious involvement and dedicated efforts of non-profit
healthcare organizations are further boosting the global tuberculosis
testing market. Growing tuberculosis cases have also resulted in
increased research and development budgets, encouraging manufacturers
to launch better testing technologies.
Browse Full Press
Release Report :
http://www.transparencymarketresearch.com/pressrelease/tuberculosis-testing-market.htm
Serological Tests
and IGRA Sub-segments to Grow the Fastest
The global
tuberculosis testing market is classified on the basis of type and
geography. The segments by product type are culture-based tests,
smear microscopy, nucleic acid testing, radiography (chest x-ray),
Mantoux test (tuberculin skin test), drug susceptibility test (DST),
and other tests such as serological tests, ADA, and IGRA.
Geographically, the global tuberculosis testing market is fragmented
into North America, Asia Pacific, Europe, and Rest of the World.
Out of these
segments, culture-based tests hold a lion’s share in the global
tuberculosis testing market. These tests are inclusive of both solid
and liquid culture tests. Analysts predict that other segments such
as serological tests and IGRA will grow rapidly in the coming five
years as well. All of these tuberculosis testing methods generate
quick results, offer improved accuracy, and require the patient to
just one visit.
India and China to
Make Steady Contribution to Growth of Global Tuberculosis Market
Geographically, Asia
Pacific led the global tuberculosis testing market in 2013, closely
followed by North America. The prime factor driving the unprecedented
growth rate in Asia Pacific is a huge patient pool, which continues
to grow at a rapid rate, especially in countries such as China and
India. Though North America has a smaller patient pool, the
tuberculosis testing market is expected to grow in this region due to
increasing awareness, better healthcare infrastructure, and growing
acceptance and adoption of expensive TB tests due to improving
purchasing power of patients.
Some of the key
players in the global tuberculosis testing market are Akonni
Biosystems Inc., Abbott Laboratories, Becton, Alere Inc., Dickinson
and Company, Cepheid, Epistem plc, bioMérieux SA, F. Hoffmann-La
Roche Ltd., Hologic, QIAGEN, Hain Lifescience GmbH, Sanofi, and
Thermo Fisher Scientific Inc.
Request a Brochure
of this Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=2267
About Us
Transparency Market
Research is a global market intelligence company, providing global
business information reports and services. Our exclusive blend of
quantitative forecasting and trends analysis provides forward-looking
insight for thousands of decision makers. Our experienced team of
Analysts, Researchers, and Consultants, use proprietary data sources
and various tools and techniques to gather, and analyze information.
Our data repository
is continuously updated and revised by a team of research experts, so
that it always reflects the latest trends and information. With a
broad research and analysis capability, Transparency Market Research
employs rigorous primary and secondary research techniques in
developing distinctive data sets and research material for business
reports.
Contact
Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll
Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
http://www.transparencymarketresearch.com
No comments:
Post a Comment